Sex Steroids, the Meibomian Gland and Evaporative Dry Eye

  • D. A. Sullivan
  • H. Yamagami
  • M. Liu
  • R. J. Steagall
  • F. Schirra
  • T. Suzuki
  • K. L. Krenzer
  • J. M. Cermak
  • R. M. Sullivan
  • S. M. Richards
  • D. A. Schaumberg
  • M. R. Dana
  • B. D. Sullivan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 506)


Our recent research has led to our hypothesis that gender and sex steroid hormones are critical factors in the regulation of the meibomian gland and pathogenesis of evaporative dry eye. The objective of this article is to briefly summarize the experimental basis for this hypothesis.


Rose Bengal Sodium Fluorescein Keratoconjunctivitis Sicca Present Pain Intensity Fluid Portion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sullivan DA, Dartt DA, Meneray MM, editors. Lacrimal Gland, Tear Film and Dry Eye Syndromes 2. Basic Science and Clinical Relevance. New York: Plenum Press; 1998.Google Scholar
  2. 2.
    Sullivan DA. Ocular mucosal immunity. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee J, Bienenstock J, editors. Handbook of Mucosal Immunology, 2nd Edition. Orlando, FL: Academic Press; 1999. pp. 1241–1281.Google Scholar
  3. 3.
    Dartt DA, Sullivan DA. Wetting of the ocular surface. In Albert DM, Jakobiec, FA, editors. Principles and Practice of Ophthalmology, 2nd Edition. Philadelphia, PA: WB Saunders Company; 2000. vol. 2, p. 960–981.Google Scholar
  4. 4.
    Dursun D, Monroy D, Knighton R, Tervo T, Vesaluoma M, Carraway K, Feuer W, Pflugfelder SC. The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology 2000; 107:1754–1760.CrossRefPubMedGoogle Scholar
  5. 5.
    Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.PubMedGoogle Scholar
  6. 6.
    Lemp MA, Marquardt R, eds. The Dry Eye. Berlin: Springer-Verlag, 1992.Google Scholar
  7. 7.
    Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996; 40:343–367.CrossRefPubMedGoogle Scholar
  8. 8.
    Sullivan DA, Wickham LA, Krenzer KL, Rocha EM, Toda I. Aqueous tear deficiency in Sjögren’s syndrome: possible causes and potential treatment. In: Pleyer U, Hartmann C, Sterry W, eds. Oculodermal Diseases — Immunology of Bullous Oculo-Muco-Cutaneous Disorders. Buren, The Netherlands: Aeolus Press, 1997:95–152.Google Scholar
  9. 9.
    Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren’s Syndrome. Clinical and Immunological Aspects. Berlin: Springer Verlag 1987.Google Scholar
  10. 10.
    Fox RI, editor. Sjögren’s Syndrome. Rheum Dis Clin NA. 1992; vol 18.Google Scholar
  11. 11.
    Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, editors. Sjögren’s Syndrome. State of the Art. Amsterdam: Kugler Press 1994.Google Scholar
  12. 12.
    Saito I, Terauchi K, Shimuta M, Nishiimura S, Yoshino K, Takeuchi T, Tsubota K, Miyasaka N. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjögren’s syndrome. J Clin Lab Anal. 1993; 7:180–187.CrossRefPubMedGoogle Scholar
  13. 13.
    Rocha EM, Wickham LA, Huang Z, Toda I, Gao J, Silveira LA, Sullivan DA. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren’s syndrome. Adv Exp Med Biol. 1998; in press.Google Scholar
  14. 14.
    Toda I, Wickham LA, Sullivan DA. Gender and androgen treatment influences the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice. Clin Immunol Immunopath. 1998; 86:59–71.CrossRefGoogle Scholar
  15. 15.
    Toda I, Sullivan BD, Wickham LA, Sullivan DA. Gender and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. J Steroid Biochem Mol Biol. 1999;71:49–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Sullivan DA. Sex hormones and Sjögren’s syndrome. J Rheumatol. 1997; 24 (Suppl 50): 17–32.Google Scholar
  17. 17.
    Toda I, Sullivan BD, Rocha EM, Silveira LA, Wickham LA, Sullivan DA. Impact of gender on exocrine gland inflammation in mouse models of Sjögren’s syndrome. Exp Eye Res. 1999;69:355–366.CrossRefPubMedGoogle Scholar
  18. 18.
    Tornwall J, Lane TE, Fox RI, Fox HS. T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. Lab Invest. 1999; 79:1719–1726.PubMedGoogle Scholar
  19. 19.
    Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjøgren’s syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res. 1998;17:1135–1142.CrossRefPubMedGoogle Scholar
  20. 20.
    Robinson CP, Cornelius J, Bounous DE, Yamamoto H, Humphreys-Beher MG, Peck AB. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity 1998; 27:29–44.CrossRefPubMedGoogle Scholar
  21. 21.
    Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjøgren’s syndrome. Invest Ophthalmol Vis Sci. 1998; 39:151–156.PubMedGoogle Scholar
  22. 22.
    Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol. 1998;116:849–852.CrossRefPubMedGoogle Scholar
  23. 23.
    Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995; 113:1266–1270.CrossRefPubMedGoogle Scholar
  24. 24.
    Caffery BE, Richter D, Simpson T, Fonn D, Doughty M, Gordon K. CANDEES: The Canadian dry eye epidemiology study. Adv Exp Med Biol. 1998;438:805–806.CrossRefPubMedGoogle Scholar
  25. 25.
    McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105:1114–1119.CrossRefPubMedGoogle Scholar
  26. 26.
    PharMetrics/NDC Health Information Services. Prevalence and treatment of dry eye in a managed care population. Draft Report 2000.Google Scholar
  27. 27.
    Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2001; in press.Google Scholar
  28. 28.
    Versura P, Profazio V, Cellini M, Torreggiani A, Caramazza R. Eye discomfort and air pollution. Ophthalmologica 1999; 213:103–109.CrossRefPubMedGoogle Scholar
  29. 29.
    Caffery B, Richter D, Simpson T, Fonn D, Doughty M, Gordon K. The prevalence of dry eye in contact lens wearers: Part 2 of the Canadian dry eye epidemiology study (CANDEES). Invest Ophthalmol Vis Sci. 1996; 37:S72.Google Scholar
  30. 30.
    Krenzer KL, Cermak JM, Tolls DB, Papas AS, Dana MR, Sullivan DA. Comparative signs and symptoms of dry eye in primary and secondary Sjögren’s syndrome and meibomian gland disease. Invest Ophthalmol Vis Sci. 1999; 40:S2864.Google Scholar
  31. 31.
    Nabata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. Histopathological study of the human meibomian glands. Invest Ophthalmol Vis Sci Suppl. 1994; 35:1789.Google Scholar
  32. 32.
    Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992; 11:334–342.CrossRefPubMedGoogle Scholar
  33. 33.
    Tiffany JM. Individual variations in human meibomian lipid composition. Exp Eye Res. 1978; 27:289–300.CrossRefPubMedGoogle Scholar
  34. 34.
    Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res. 1987; 22:1–62.CrossRefPubMedGoogle Scholar
  35. 35.
    Tiffany JM. Physiological functions of the meibomian glands. Prog Retinal Eye Res. 1995; 14:47–74.CrossRefGoogle Scholar
  36. 36.
    McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997; 95:79–88.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997; 74:8–13, 1997.CrossRefPubMedGoogle Scholar
  38. 38.
    Yokoi N, Mossa F, Tiffany JM, Bron AJ. Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol. 1999; 117:723–729.CrossRefPubMedGoogle Scholar
  39. 39.
    Mathers WD, Daley TE. Tear flow and evaporation in patients with and without dry eye. Ophthalmol. 1996; 103:664–669, 1996.CrossRefGoogle Scholar
  40. 40.
    Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989; 69:383–416.PubMedGoogle Scholar
  41. 41.
    Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab. 1993; 76:524–528.PubMedGoogle Scholar
  42. 42.
    Miyake K, Ciletti N, Liao S, Rosenfield RL. Androgen receptor expression in the preputial gland and its sebocytes. J Invest Dermatol. 1994; 103:721–725.CrossRefPubMedGoogle Scholar
  43. 43.
    Luu-The V, Sugimoto Y, Puy L, Labrie Y, Solache IL, Singh M, Labrie F. Characterization, expression, and immunohistochemical localization of 5a-reductase in human skin. J Invest Dermatol. 1994;102:221–226.CrossRefPubMedGoogle Scholar
  44. 44.
    Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol. 1999; 113:1011–20.CrossRefPubMedGoogle Scholar
  45. 45.
    Ito A, Sakiguchi T, Kitamura K, Akamatsu H, Horio T. Establishment of a tissue culture system for hamster sebaceous gland cells. Dermatology 1998; 197:238–44.CrossRefPubMedGoogle Scholar
  46. 46.
    Akamatsu H, Zouboulis CC, Orfanos CE. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol. 1992; 99:509–511.CrossRefPubMedGoogle Scholar
  47. 47.
    Luderschmidt C, Eiermann W, Jawny J. Steroid hormone receptors and their relevance for sebum production in the sebaceous gland ear model of the Syrian hamster. Arch Dermatol Res. 1983; 275:175–180.CrossRefPubMedGoogle Scholar
  48. 48.
    Hall DW, Van den Hoven WE, Noordzij-Kamermans NJ, Jaitly KD. Hormonal control of hamster ear sebaceous gland lipogenesis. Arch Dermatol Res. 1983; 275:1–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Strauss JS, Pochi PE. The human sebaceous gland: its regulation by steroidal hormones and its use as an end organ for assaying androgenicity in vivo. Rec Prog Horm Res. 1963; 19:385.PubMedGoogle Scholar
  50. 50.
    Puy LA, Turgeon C, Gagne D, Labrie Y, Chen C, Pelletier G, Simard J, Labrie F. Localization and regulation of expression of the FAR-17A gene in the hamster flank organs. J Invest Dermatol. 1996; 107:44–50.CrossRefPubMedGoogle Scholar
  51. 51.
    Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol. 1992; 128:1345–1348.CrossRefPubMedGoogle Scholar
  52. 52.
    Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol. 1992; 133:467–475.CrossRefPubMedGoogle Scholar
  53. 53.
    Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000; 21:363–392.CrossRefPubMedGoogle Scholar
  54. 54.
    Hamilton JB. Male hormone substance: a prime factor in acne. J Clin Endocrinol Metab. 1941; 1:570.CrossRefGoogle Scholar
  55. 55.
    Rony HR, Zakon SJ. Effect of androgen on the sebaceous glands of human skin. Arch Dermatol Syphilol. 1943;48:601–604.CrossRefGoogle Scholar
  56. 56.
    Zouboulis CC, Akamatsu H, Stephanek K, Orfanos CE. Androgens affect the activity of human sebocytes in culture in a manner dependent on the localization of the sebaceous glands and their effect is antagonized by spironolactone. Skin Pharmacol. 1994; 7:33–40.CrossRefPubMedGoogle Scholar
  57. 57.
    Pochi PE. Acne: endocrinologie aspects. Cutis 1982; 30:212–222.PubMedGoogle Scholar
  58. 58.
    Pochi PE, Strauss JS. Endocrinologie control of the development and activity of the human sebaceous gland. J Invest Dermatol. 1974; 62:191–201.CrossRefPubMedGoogle Scholar
  59. 59.
    Schroder HG, Ziegler M, Nickisch K, Kaufmann J, el Etreby MF. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs. J Invest Dermatol. 1989; 92:769–773.CrossRefPubMedGoogle Scholar
  60. 60.
    Emanuel SV. Quantitative determinations of the sebaceous glands’ function, with particular mention of the method employed. Acta Derm Venereol (Stockh) 1936; 17:444–456.Google Scholar
  61. 61.
    Smith JG, Brunot FR. Hormonal effects on aged human sebaceous glands. Acta Derm Venereol (Stockh) 1961; 41:61–65.Google Scholar
  62. 62.
    Wirth H, Gloor M, Kimmel W. Influence of cyproterone acetate and estradiol on cell kinetics in the sebaceous gland of the golden hamster ear. Arch Dermatol Res. 1980; 268:277–281.CrossRefPubMedGoogle Scholar
  63. 63.
    Bologna JL. Aging skin. Am J Med Suppl. 1995; 1 A:99S–102S.CrossRefGoogle Scholar
  64. 64.
    Ideta R, Seki T, Adachi K. Sequence analysis and characterization of FAR-17c, an androgen-dependent gene in the flank organs of hamsters. J Derm Sci. 1995; 9:94–102.CrossRefGoogle Scholar
  65. 65.
    Gross SK, Lyerla TA, Evans JE, McCluer RH. Expression of glycosphingolipids in serum-free primary cultures of mouse kidney cells: male-female differences and androgen sensitivity. Mol Cell Biochem. 1994;137:25–31.CrossRefPubMedGoogle Scholar
  66. 66.
    Hall RE, Birrell SN, Tilley WD, Sutherland RL. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 1994; 30A:484–490.CrossRefGoogle Scholar
  67. 67.
    Cinci G, Pagani R, Pandolfi ML, Porcelli B, Pizzichini M, Marinello E. Effects of testosterone on cholesterol levels and fatty acid composition in the rat. Life Sci. 1993; 53:91–97.CrossRefPubMedGoogle Scholar
  68. 68.
    Yamamoto A, Ito M. Sebaceous gland activity and urinary androgen levels in children. J Derm Sci. 1992; 4:98–104.CrossRefGoogle Scholar
  69. 69.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 1997; 57:1086–1090.PubMedGoogle Scholar
  70. 70.
    Swinnen JV, van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocr. 1996; 137:4468–474.CrossRefGoogle Scholar
  71. 71.
    Seyama Y, Hida A, Hayashi S, Buzzell GR. Androgenic control of l-alkyl-2,3-diacylglycerol in the Harderian gland of the golden hamster, Mesocricetus auratus. J Biochem. 1996; 119:799–804.CrossRefPubMedGoogle Scholar
  72. 72.
    Ojeda MS, Gomez N, Gim’nez MS. Androgen regulation of lung lipids in the male rat. Lipids 1997; 32:57–62.CrossRefPubMedGoogle Scholar
  73. 73.
    Marra CA, de Alaniz MJ. Regulatory effect of various steroid hormones on the incorporation and metabolism of [14C]stearate in rat hepatoma cells in culture. Mol Cell Biochem. 1995; 145:1–9.CrossRefPubMedGoogle Scholar
  74. 74.
    Swinnen JV, Ulrix W, Heyns W, Verhoeven G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 1997; 94:12975–12980.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Ster Biochem Mol Biol. 1998; 65:191–198.CrossRefGoogle Scholar
  76. 76.
    Swinnen JV, Heyns W, Verhoeven G. Androgen regulation of lipogenesis. Adv Exp Med Biol. 2001 ; in press.Google Scholar
  77. 77.
    Sullivan DA, Sullivan BD, Ullman MD, Rocha EM, Krenzer KL, Cermak JM, Toda I, Doane M, Evans JE, Wickham LA. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci. 2000; 41:3732–3742.PubMedGoogle Scholar
  78. 78.
    Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmologica 2000;78:146–153.CrossRefGoogle Scholar
  79. 79.
    Rocha EM, Wickham LA, Silveira LA, Krenzer KL, Yu FS, Toda I, Sullivan BD, Sullivan DA. Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues. Brit J Ophthalmol. 2000;84:76–84.CrossRefGoogle Scholar
  80. 80.
    Yamagami H, Richards SM, Sullivan BD, Liu M, Steagall RJ, Sullivan DA. Gender-associated differences in gene expression of the meibomian gland. Adv Exp Med Biol. 2001; in press.Google Scholar
  81. 81.
    Yamagami H, Schirra F, Liu M, Richards SM, Sullivan BD, Sullivan DA. Androgen influence on gene expression in the meibomian gland. Adv Exp Med Biol. 2001; in press.Google Scholar
  82. 82.
    Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol. 2001; in press.Google Scholar
  83. 83.
    Schirra F, Liu M, Sullivan DA. Androgen control of gene expression in the mouse meibomian gland. Abstract, European Vision and Eye Research Meeting (October, 2001, Alicante, Spain).Google Scholar
  84. 84.
    Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls BD, Evans JE, Sullivan DA. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocr Metab. 2000; 85:4874–4882.PubMedGoogle Scholar
  85. 85.
    Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Impact of anti-androgen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocr Metab. 2000; 85:4866–4873.PubMedGoogle Scholar
  86. 86.
    Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol. 2001; in press.Google Scholar
  87. 87.
    Cermak JM, Krenzer KL, Dana MR, Sullivan DA. Do individuals with complete androgen insensitivity display the signs and symptoms of dry eye? Invest Ophthalmol Vis Sci. 1999; 40:S2836.Google Scholar
  88. 88.
    Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Complete androgen insensitivity syndrome: influence on the polar and neutral lipid profiles of human meibomian gland secretions. Manuscript submitted, 2001.Google Scholar
  89. 89.
    Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Effect of aging on lipid patterns in human meibomian gland secretions. Manuscript submitted, 2001.Google Scholar
  90. 90.
    Zeligs MA, Gordon K. Dehydroepiandrosterone therapy for the treatment of dry eye disorders. Int Patent Application WO 94/04155, March, 1994.Google Scholar
  91. 91.
    Radnót VM, Németh B. Wirkung der Testosteronpräparate auf die Tränendrüse. Ophthalmologica 1955; 129:376–380.CrossRefPubMedGoogle Scholar
  92. 92.
    Radnót M, Nemeth B. Testosteronkészítmények hatàsa a könnymirigyre. Orvosi Hetilap 1954; 95:580–581.PubMedGoogle Scholar
  93. 93.
    Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and the prevalence of dry eye syndrome. Submitted, 2001.Google Scholar
  94. 94.
    Schafer G, Krause W. The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen. Arch Dermatol Res. 1985; 277:230–234.CrossRefPubMedGoogle Scholar
  95. 95.
    Sweeney TM, Szarnicki RJ, Strauss JS, Pochi PE. The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol. 1969; 53:8–10.CrossRefPubMedGoogle Scholar
  96. 96.
    Strauss JS, Kligman AM, Pochi PE. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol. 1962; 39:139–155.CrossRefPubMedGoogle Scholar
  97. 97.
    Sansone-Bazzano G, Reisner RM, Bazzano G. A possible mechanism of action of estrogen at the cellular level in a model sebaceous gland. J Invest Dermatol. 1972; 59:299–304.CrossRefPubMedGoogle Scholar
  98. 98.
    Saihan EM, Burton JL. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy. Br J Dermatol. 1980; 103:139–142.CrossRefPubMedGoogle Scholar
  99. 99.
    Pochi PE, Strauss JS. Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment. Arch Dermatol. 1976; 112:1108–1109.CrossRefPubMedGoogle Scholar
  100. 100.
    Smith E, Szego CM. Direct photomicroscopic evidence for rapid nuclear penetration of lysosomal products in steroid targets after estrogen in vivo. Endocrinol. 1971; 88: Suppl XRA-151:A151.Google Scholar
  101. 101.
    Gurwood AS, Gurwood I, Gubman DT, Brzezick LJ. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72:29–33.CrossRefPubMedGoogle Scholar
  102. 102.
    Verbeck B. Augenbefunde und stoffwechselverhalten bei einnahme von Ovulationshemmern. Klin Mbl Augenheilk 1973; 162:612–621.PubMedGoogle Scholar
  103. 103.
    Christ T, Marquardt R, Stodtmeister R, Pillunat LE. Zur Beeinflussung der tränenfilmaufreibzeit durch hormonale kontrazeptiva. Fortschr Ophthalmol. 1986; 83:108–111.PubMedGoogle Scholar
  104. 104.
    Brennan NA, Efron N. Symptomatology of HEMA contact lens wear. Optom Vis Sci. 1989;66:834–838.CrossRefPubMedGoogle Scholar
  105. 105.
    Ruben M. Contact lenses and oral contraceptives. Brit Med J. 1966; 1: 1110.CrossRefPubMedCentralGoogle Scholar
  106. 106.
    Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 2000; 107:180–184.CrossRefPubMedGoogle Scholar
  107. 107.
    Suzuki T, Schaumberg DA, Sullivan BD, Liu M, Richards SM, Sullivan RM, Dana MR, Sullivan DA. Do estrogen and progesterone play a role in the dry eye of Sjögren’s syndrome. Ann NY Acad Sci 2001; in press.Google Scholar
  108. 108.
    Suzuki T, Sullivan BD, Liu M, Schirra F, Richards SM, Yamagami H, Sullivan DA. Estrogen and progesterone effects on the morphology of the mouse meibomian gland. Adv Exp Med Biol. 2001; in press.Google Scholar
  109. 109.
    Sullivan BD, Evans JE, Sullivan RM, Schaumberg DA, Dana MR, Sullivan DA. Impact of hormone replacement therapy on the lipid profile of meibomian gland secretions in postmenopausal women. Manuscript submitted, 2001.Google Scholar
  110. 110.
    Chew CKS, Hykin PG, Janswijer C, Dikstein S, Tiffany JM, Bron AJ. The casual level of meibomian lipids in humans. Curr Eye Res. 1993;12:255–259.CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 2002

Authors and Affiliations

  • D. A. Sullivan
    • 1
    • 2
  • H. Yamagami
    • 1
    • 2
  • M. Liu
    • 1
    • 2
  • R. J. Steagall
    • 1
  • F. Schirra
    • 1
    • 2
  • T. Suzuki
    • 1
    • 2
  • K. L. Krenzer
    • 3
  • J. M. Cermak
    • 1
    • 2
  • R. M. Sullivan
    • 1
  • S. M. Richards
    • 1
  • D. A. Schaumberg
    • 1
    • 2
    • 4
  • M. R. Dana
    • 1
    • 2
    • 4
  • B. D. Sullivan
    • 1
  1. 1.Schepens Eye Research InstituteBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA
  3. 3.New England College of OptometryBostonUSA
  4. 4.Brigham and Women’s HospitalBostonUSA

Personalised recommendations